Key facts
- Vega Health’s last known valuation is $24.7M (Oct 2025).
- It has raised $5.0M across 1 recorded rounds; the latest was Seed Round ($5.0M) in Dec 2025.
- Notable investors include Bessemer Venture Partners, Edge (Onalaska).
- Vega Health has filed 1 Form D with the SEC, most recently Sep 2025 ($4.0M sold to 3 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Vega Health
Funding rounds
1 roundsAbout Vega Health
Developer of healthcare AI implementation and monitoring services designed to integrate third-party models into health systems. The company's platform curates a marketplace of clinically validated models from health organizations and innovators, offers local installation and workflow integration, provides pre-implementation testing against patient data, continuous technical and clinical performance monitoring, outcome reporting, and co-development capabilities for custom models, enabling health systems to select, deploy, measure ROI, and scale tools objectively while helping innovators commercialize through distribution and revenue sharing.
- Industry
- Other Healthcare Technology Systems
- Sector
- Healthcare
- HQ
- Durham, NC, United States
- Founded
- 2025
- Website
- vegahealth.com/
- Ownership
- Privately Held (backing)
Vega Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vega Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vega Health in its N-PORT filings yet. We sweep new filings monthly.